Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<ul><li>Shares of <keyword id="11546988" type="UNKNOWN" weightage="20" keywordseo="Clean-Science-and-Technology">Clean Science and Technology</keyword> list at over 100% premium from its price band of ₹880-900 per share.</li><li>The IPO was subscribed 95.54 times on the last day of the bidding.</li><li>The market capitalisation of the company stood at ₹16,786 crore. </li></ul>Shares of Clean Science and Technology made a very strong listing on National Stock Exchange (NSE) and BSE at over 100% premium from its price band of ₹880-900 per share. Post listing, the market capitalisation of the company stood at ₹16,786 crore, according to BSE data. The shares of Clean Science and Technology were trading at ₹1,590 at 10.15 a.m., on July 19. The grey market premium of the stock had suggested a 60-70% premium over the issue price. Moreover, the IPO had received a positive response from investors considering that investors had bid for 114.92 crore equity shares against the IPO size of 1.23 crore equity shares. The issue was open for subscription between June 7 and June 9. The IPO was a complete offer for sale (OFS) by existing promoters and other shareholders. The entire ₹1,546 crore share sale ⁠— priced at ₹880-900 apiece⁠ was from existing investors Ashok Ramnarayan Boob (₹244 crore), Krishnakumar Ramnarayan Boob (₹193 crore), Siddhartha Ashok Sikchi (₹40 crore) and Parth Ashok Maheshwari (₹75 crore). Clean Science and Technology is among the few companies, globally, focused entirely on developing newer technologies using in-house catalytic processes, which are eco-friendly and cost competitive. The company manufactures critical speciality chemicals such as performance chemicals, pharmaceutical intermediates, fast moving consumer goods (FMCG) chemicals and other products. SEE ALSO: <a href="https://www.businessinsider.in/tech/apps/news/whatsapp-multi-device-beta-how-to-download/articleshow/84542073.cms">WhatsApp multi-device beta – here’s how it works and how you can get it </a> <a href="https://www.businessinsider.in/careers/news/it-engineers-web-developers-students-can-take-benefits-of-state-government-internships/slidelist/84519217.cms">IT engineers, web developers and more — State governments are inviting applications for paid internships </a>

Clean Science and Technology IPO: Shares list at 100% premium on exchanges

<ul><li><keyword id="11546988" type="UNKNOWN" weightage="20" keywordseo="Clean-Science-and-Technology">Clean Science and Technology</keyword>’s ₹1,546 crore IPO has opened for subscription and investors can apply till July 9. </li><li>The IPO has a price band of ₹880-900 per share. </li><li>The IPO is a complete offer for sale (OFS) by existing promoters and other shareholders to reduce their stake in the firm.</li><li>Most analysts have recommended subscribing to the specialty chemical manufacturer’s IPO on strong industry outlook and financials of the company. </li></ul>Clean Science and Technology is said to be one of the largest manufacturers of certain specialty chemicals in the country. And it’s investors are trying to cash out of the Pune-based company through the initial public offering (IPO), from July 7-9, at a time when the tide is in favour of the entire sector. The entire ₹1,546 crore share sale ⁠— priced at ₹880-900 a piece⁠ — will be from existing investors Ashok Ramnarayan Boob (₹244 crore), Krishnakumar Ramnarayan Boob (₹193 crore), Siddhartha Ashok Sikchi (₹40 crore) and Parth Ashok Maheshwari (₹75 crore). Even though the company is not using the IPO money to expand its business, broking firms recommend that investors must subscribe. “We believe that the Indian specialty chemical industry is going to be one of the biggest beneficiaries of shifting of supply chains post the COVID-19 pandemic. Given the company’s financial performance, industry leading returns ratios and favourable outlook for the industry we recommend ‘subscribe’ to the IPO issue, said Angel Broking in a report. <table style="border-width: initial; border-style: none;"></colgroup><tbody><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Broking House </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Recommendation </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Hem Securities </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Subscribe </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">BP Wealth </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Subscribe </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Canara Bank Securities </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Subscribe </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Aditya Birla Capital </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Subscribe </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Investmentz </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Subscribe </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Angel Broking </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Subscribe </td></tr></tbody></table> The pandemic has been a blessing in disguise for the specialty chemicals sector. The stalling of imports from China in the last year translated to more buyers in India, who were otherwise buying from China, leading to a 20% revenue growth for the company in the year ending March 2021. “Since specialty chemicals come under essential services, there was not a very strong impact of the lockdown on our financials, but yes demand was impacted. For some products there was low demand and for some demand was significantly better. In fact, our revenues went up over 20% in FY2020,” Siddhartha Ashok Sikchi, promoter and wholetime director, told Business Insider <a href="https://www.businessinsider.in/stock-market/news/clean-science-and-technology-ipo-the-company-has-net-cash-of-192-crore/articleshow/84165887.cms">in a recent interview</a>. The disruption in global supply from China has also got them more buyers in other parts of the world. <table style="border-width: initial; border-style: none;"></colgroup><tbody><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Particulars </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">FY19 </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">FY20 </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">FY21 </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Revenue from operations </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">393 </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">419 </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">512 </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Net profit </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">97.7 </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">139.6 </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">198.4 </td></tr></tbody></table>(in crores) Source: Report by Investmentz.com The company manufactures critical specialty chemicals such as performance chemicals, pharmaceutical intermediates, fast moving consumer goods (FMCG) chemicals and other products. More than two-thirds of the company’s revenue comes from export clients in China, Canada, Europe, the United States of America, Taiwan, Korea, and Japan. Some of the company’s key customers include: <table style="border-width: initial; border-style: none; table-layout: fixed; width: 468pt;"></colgroup><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Company </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Segment </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Bayer AG and SRF </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Agrochemicals </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Gennex Labs </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Pharmaceutical intermediaries </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Vinati Organics </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Monomer products </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Nutriad International NV </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Animal nutrition products </td></tr></tbody></table>Source: Hem Securities report dated July 6 Some of the company's customers have also been associated with the company for over 10 years, the report added. However, in the last three years, the company has reduced its dependence on top clients. Revenue from top 10 clients fell from over half of total revenue in the financial year 2019 to 47.9% at the end of March 2021. The global specialty chemicals market is projected to grow at an annual compounded rate of 5% to reach $1.09 trillion by 2025. Some of the segments such as pharma APIs, agrochemicals, construction chemicals, home &amp; personal care and additives are poised to grow at much higher rates than the overall industry, said Aditya birla Capital in a report dated July 5. No wonder, then, peer companies that are listed have given investors remarkable returns in the last one year. <table style="border-width: initial; border-style: none; table-layout: fixed; width: 468pt;"></colgroup><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Stock </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Last 12 months change (From June 2020 to June 2021) </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Vinati Organics </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">80% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Fine Organic Industries </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">49% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Atul </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">98.9% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">SRF </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">108% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Camlin Fine Science </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">356% </td></tr></tbody></table> SEE ALSO: <a href="https://www.businessinsider.in/tech/news/a-small-hospital-assam-is-using-ai-to-detect-strokes-in-tea-planters/articleshow/84194042.cms">A small hospital Assam is using AI to detect strokes in tea planters (businessinsider.in)</a> <a href="https://www.businessinsider.in/stock-market/news/gr-infraprojects-ipo-good-ipo-bet-for-long-term-as-per-analysts/articleshow/84193656.cms">GR Infraprojects IPO is for long term investors, say analysts | Business Insider India</a>

Clean Science and Technology, an Indian supplier to Bayer, has opened its IPO ⁠— and ‘subscribe’ is the unanimous call from analysts

<ul><li>The <keyword id="6354763" type="UNKNOWN" weightage="20" keywordseo="ipo">IPO</keyword> is entirely an offer for sale (<keyword id="883402" type="ORGANIZATION" weightage="20" keywordseo="OFS">OFS</keyword>) by existing promoters and shareholders.</li><li>Pune-based specialty chemicals company <keyword id="11546988" type="UNKNOWN" weightage="20" keywordseo="Clean-Science-and-Technology">Clean Science and Technology</keyword> looks to raise ₹1,546 crore through the public issue.</li><li>The bidding process for the IPO will start on July 7 and end on July 9.</li></ul>Pune-based specialty chemicals company Clean Science and Technology has set the <keyword id="108724" type="PERSON" weightage="20" keywordseo="price-band">price band</keyword> for its initial public offering (IPO) at ₹880-900 while it looks to raise ₹1,546 crore through the public issue. The IPO is completely an offer for sale (OFS) by existing promoters and other shareholders wherein the company will not receive any proceeds from the offer and all the proceeds will be received by the selling shareholders and promoters. The major <keyword id="48705" type="PERSON" weightage="20" keywordseo="share-sale">share sale</keyword> by the company’s promoters include Ashok Ramnarayan Boob (₹244 crore), Krishnakumar Ramnarayan Boob (₹193 crore), Siddhartha Ashok Sikchi (₹40 crore) and Parth Ashok Maheshwari (₹75 crore). Clean Science and Technology is among the few companies, globally, focused entirely on developing newer technologies using in-house catalytic processes, which are eco-friendly and cost competitive. The company manufactures critical specialty chemicals such as performance chemicals, pharmaceutical intermediates, fast moving consumer goods (FMCG) chemicals and other products. The IPO lot size is 16 shares. The company has reserved up to 50% of the offer for qualified institutional buyers, 35% for retail investors, and 15% for non-institutional buyers. In fiscal 2021, the company’s revenue from operations for sales outside India represented 67.86% of total revenue from operations. The company net profit for the period stood at ₹198 crore along with ₹192 crore net cash from operating activities. The bidding process will start on July 7 and end on July 9. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/cryptocurrency/news/faze-clan-pump-and-dump-crypto-scam-gets-kay-kicked-off-and-three-others-suspended/articleshow/84063180.cms">E-sports group FaZe Clan is distancing itself from gamers accused of running a ‘pump and dump’ crypto scam</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/thelife/personalities/news/gautam-adani-and-family-slip-out-of-worlds-top-20-billionaires-as-per-forbes/articleshow/84062686.cms">Gautam Adani and family slip out of world’s top 20 billionaires, as per Forbes</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/tech/apps/news/google-is-working-on-a-new-app-to-let-you-store-your-medical-records/articleshow/84059948.cms">Google is working on a new app to let you store your medical records</a>

Clean Science and Technology sets IPO price band at ₹880-900, bidding to start on July 7

<ul><li>The company is likely to announce its share allotment status on July 14</li><li>The IPO of the speciality chemical manufacturer was subscribed 95.54 times on the last day of bidding</li><li>Investors have bid for 114.92 crore shares against the 1.23 crore shares on offer.</li></ul>Pune-based speciality chemical manufacturer Clean Science and Technology is likely to announce the allotment of its initial public offering (IPO) status on July 14. The IPO was open for subscription between July 7 and July 9. The company is looking to raise ₹1,546 crore through the IPO. The entire ₹1,546 crore share sale ⁠— priced at ₹880-900 apiece⁠ was from existing investors Ashok Ramnarayan Boob (₹244 crore), Krishnakumar Ramnarayan Boob (₹193 crore), Siddhartha Ashok Sikchi (₹40 crore) and Parth Ashok Maheshwari (₹75 crore). The IPO has received a blockbuster response from investors, especially from qualified institutional buyers and non-institutional investors as investors have bid for 114.92 crore shares against the 1.23 crore shares on offer. The portion for qualified institutional investors was subscribed 159.93 times while the non-institutional investor category received a bid for 211.12 times. In an interview with Business Insider ahead of the IPO, the company’s promoter and wholetime director of the company, Siddhartha Ashok Sikchi, shared how the company holds enough cash in hand and is not looking to raise any primary capital. Here is how to check <keyword id="11626687" type="UNKNOWN" weightage="20" keywordseo="clean-science-and-technology-ipo-allotment">Clean Science and technology IPO allotment</keyword> status on stock exchange website: <ul><li>Go to the <a href="https://www.bseindia.com/investors/appli_check.aspx">BSE website</a> or NSE website<a href="https://www1.nseindia.com/products/dynaContent/equities/ipos/ipo_login.jsp"> here</a>.</li><li>On BSE, Select 'Equity' and then from the dropdown, select 'Clean Science and Technology.</li><li>Now, enter your application number and PAN.</li><li>Click on 'Search'.</li><li>Please note the details will only be available once the shares are allotted.</li></ul>You can also visit the registrar website (Link Intime India) to check your application status. <ul><li>Visit the registrar's website <a href="https://linkintime.co.in/MIPO/Ipoallotment.html">here</a>.</li><li>Click on 'Select company' and click on 'Clean Science and Technology’. </li><li>Once the company is selected, you will have to enter either your PAN detail, the application number, or the client ID.</li><li>Enter the captcha and click ’submit’.</li></ul>Once you hit 'submit', the status of your application will appear on the screen. Please ensure the details that you provide are correct. It will show the number of shares you subscribed to and the number of shares allotted to you. SEE ALSO: <a href="https://www.businessinsider.in/stock-market/news/how-to-apply-for-zomato-ipo/articleshow/84365964.cms">Zomato IPO: Here’s how to apply via banks and apps like Zerodha, Paytm Money | Business Insider India</a> <a href="https://www.businessinsider.in/business/startups/news/softbank-swiggy-deals-gets-cci-approval-two-days-before-zomato-ipo/articleshow/84347306.cms">SoftBank-Swiggy deal gets CCI approval, two days before Zomato IPO | Business Insider India</a>

Clean Science and Technology IPO - How to check allotment status, listing date and more

<ul><li>Specialty chemicals company Clean Science and Technology looks to raise ₹1,546 crore through the public issue.</li><li>The company has net cash of ₹192 crore as of March 31, 2021 from operating activities. </li><li>Another lockdown might not be a concern for the company as it comes under essential goods.</li></ul>Pune-based specialty chemicals company Clean Science and Technology is getting closer to listing its shares on the exchanges as the bidding process of the company starts on Wednesday (July 7). The company is looking to raise ₹1,546 crore through the initial public offering (IPO), which is completely an offer for sale (OFS) by existing promoters and other shareholders wherein the company will not receive any proceeds from the offer and all of it will go towards the selling shareholders and promoters. In an interview with Business Insider ahead of the IPO, the company’s promoter and wholetime director of the company, Siddhartha Ashok Sikchi shared how the company holds enough cash in hand and is not looking to raise any primary capital. “The IPO is a 100% OFS. At company level we are not raising any primary capital as we have ₹250 crore cash on board” he said. The company’s promoters who are selling shares include Ashok Ramnarayan Boob (₹244 crore), Krishnakumar Ramnarayan Boob (₹193 crore), Siddhartha Ashok Sikchi (₹40 crore) and Parth Ashok Maheshwari (₹75 crore). The company has net cash of ₹192 crore as of March 31, 2021 from operating activities. Moreover, the company says it has performed well even during the initial difficult lockdown phase last year. “Since specialty chemicals come under essential services, there was not a very strong impact of the lockdown on our financials, but yes demand was impacted. For some products there was low demand and for some demand was significantly better. In fact, our revenues went up over 20% in FY2021,” said Sikchi. The company gets a significant portion of revenues from exporting to China. <div type="image" title="Revenue mix by geography" height="900" width="1200" msid="84166095" hostid="261" caption="&amp;lt;p&amp;gt;Revenue mix by geography&amp;lt;br /&amp;gt;&amp;lt;/p&amp;gt;"></div> The company manufactures critical specialty chemicals such as performance chemicals, pharmaceutical intermediates, fast moving consumer goods (FMCG) chemicals and other products. <div type="image" title="revenue mix by product" height="900" width="1200" msid="84166105" hostid="261" caption="&amp;lt;p&amp;gt;Revenue mix by product&amp;lt;/p&amp;gt;"></div> The company derives majority of its revenue from the sale of MeHQ (hydroquinone monomethyl ether), primarily involved in the manufacturing of acrylic fibers, paints and inks, adhesives and also in the agriculture industry. In the financial year ended March 2021, revenue from the sale of MeHQ amounted to ₹246.36 crore, which is almost half of the company’s revenue from operations. Its revenue grew at an annualised rate of 14.2% between financial year 2019 and financial year 2021. Its profit after tax witnessed a compound annual growth rate (CAGR) of 42.5% during the period. SEE ALSO: <a href="https://www.businessinsider.in/business/auto/news/simple-energy-new-electric-scooter-promises-240km-range-on-a-70-minute-charge/articleshow/84164967.cms">Simple One electric scooter with 240KM range to launch on August 15: Price, features and everything else we know so far (businessinsider.in)</a> <a href="https://www.businessinsider.in/business/telecom/news/how-to-check-idea-internet-balance-on-mobile/articleshow/84163593.cms">Want to check your Vodafone-Idea internet and prepaid balance? Here is how you can do it easily | Business Insider India</a>

Clean Science and Technology not to use IPO money to expand as it has enough cash in hand

Sigachi broke Paras Defence’s record⁠—these are the five IPOs that doubled investors’ money on listing in 2021

<ul><li>The portion reserved for retail investors in the <keyword id="6354763" type="UNKNOWN" weightage="20" keywordseo="ipo">IPO</keyword> has been subscribed 9 times.</li><li>Clean Science and Technology was looking to raise ₹1,546 crore with a price band of ₹880-900 per share.</li><li>Most analysts had recommended subscribing to the speciality chemical manufacturer’s IPO on strong industry outlook and financials of the company.</li></ul>The <keyword id="47458" type="ORGANIZATION" weightage="20" keywordseo="public-issue">public issue</keyword> of Pune-based speciality chemical manufacturer Clean Science and Technology saw a blockbuster response from investors, especially from qualified institutional buyers and non-institutional investors. The issue size was subscribed 95.54 times on the third and final day of the issue on July 9 on strong interest by investors. The initial public offering (IPO) has received bids for 114.92 crore equity shares against the IPO size of 1.23 crore equity shares. <table style="border-width: initial; border-style: none;"></colgroup><tbody><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Category </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Subscription Status </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Qualified Institutional Buyers </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">159.93 times </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Non-institutional </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">211.12 times </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Retail individual </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">9.2 times </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Total </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">95.54 times </td></tr></tbody></table> Over 26.9 lakh applicants have subscribed to the IPO. Highest in recent times -- <keyword id="6354706" type="DEFINITION" weightage="20" keywordseo="IndiGo">Indigo</keyword> Paints had 25.96 lakh applicants and <keyword id="10466993" type="UNKNOWN" weightage="20" keywordseo="MTAR">MTAR</keyword> Technologies had 25.95 lakh applicants. The company’s ₹1,546 crore IPO was open for <keyword id="72984" type="PERSON" weightage="20" keywordseo="subscription">subscription</keyword> from July 7 to July 9. The entire ₹1,546 crore <keyword id="48705" type="PERSON" weightage="20" keywordseo="share-sale">share sale</keyword> ⁠— priced at ₹880-900 apiece⁠ was from existing investors Ashok Ramnarayan Boob (₹244 crore), Krishnakumar Ramnarayan Boob (₹193 crore), Siddhartha Ashok Sikchi (₹40 crore) and Parth Ashok Maheshwari (₹75 crore). Strong bidding for the IPO was also because many analysts had highly recommended investing in the IPO. The pandemic has been a blessing in disguise for the speciality chemicals sector. The stalling of imports from China in the last year translated to more buyers in India, who were otherwise buying from China, leading to a 20% revenue growth for the company in the year ending March 2021. SEE ALSO: <a href="https://www.businessinsider.in/business/startups/news/ola-app-raises-500-million-from-temasek-and-warburg-ahead-of-ipo/articleshow/84261607.cms">Ola app raises $500 million from Temasek and Warburg, ahead of IPO (businessinsider.in)</a> <a href="https://www.businessinsider.in/business/startups/news/zomato-ipo-to-open-on-july-14-with-shares-priced-at-72-76-apiece/articleshow/84226269.cms">Zomato IPO to open on July 14 ⁠with shares priced at ₹72-76 apiece | Business Insider India</a>

Clean Science and Technology IPO subscribed over 95 times on final day of bidding

HCL Tech, Adani Group, ITC and other top stocks to watch out for on July 20

Defence Research and Development Organisation (<keyword id="19948662" type="General" weightage="20" keywordseo="DRDO" source="keywords" meta.keywordsubtype="org" meta.entityname="DRDO" meta.hostid="261" meta.entityid="DRDO">DRDO</keyword>) will collaborate with <keyword id="19906424" type="General" weightage="20" keywordseo="Indian-Institute-of-Technology" source="keywords" meta.keywordsubtype="org" meta.entityname="Indian Institute of Technology" meta.hostid="261" meta.entityid="Indian Institute of Technology">Indian Institute of Technology</keyword> (<keyword id="19906425" type="General" weightage="20" keywordseo="iit" source="keywords">IIT</keyword>) Bhubaneswar for artificial intelligence (AI) driven surveillance and other projects, officials said. A meeting was held between DRDO and <keyword id="19971391" type="General" weightage="20" keywordseo="IIT-Bhubaneswar" source="keywords" meta.keywordsubtype="org" meta.entityname="IIT Bhubaneswar" meta.hostid="261" meta.entityid="IIT Bhubaneswar">IIT Bhubaneswar</keyword> officials here on Tuesday. Binay Das, director general (DG) of Electronics and Communication Systems (ECS) cluster, DRDO, and many senior scientists and officials of both institutions were present in the meeting. During the meeting, nine sanctioned projects of the ECS Cluster of DRDO were handed over to IIT Bhubaneswar while another 7 projects are in process to be sanctioned with Rs 18 crore funding. IIT Bhubaneswar will work on the sanctioned projects, which would be beneficial in electronics warfare, <keyword id="21571619" type="General" weightage="20" keywordseo="AI-driven-surveillance" source="keywords">AI-driven surveillance</keyword>, power systems, radar systems etc, officials said. S R Samantaray, head of the School of Electrical sciences of IIT said the collaboration of IIT Bhubaneswar and DRDO will contribute to the emerging research and development need of defence applications, creating a platform for 'Atma Nirbhar Bharat'. This form of collaboration will enhance the sustainability of defence research programmes and will be part of the eco-system for nation building, he said. Speaking on the occasion, Binay Das advised researchers and faculty members associated with various DRDO-sanctioned projects to work systematically with proper review and risk management systems to complete the projects in time and come up with unique solutions. He said that DRDO is going through a transformation from technology chasers to become technology enablers and trendsetters. "The goal is now to move beyond attaining self-reliance to setting standards for the Indian armed forces, for others across the globe, to emulate. In this context, this collaboration, and the further opportunity to set up a Centre of Excellence at IIT Bhubaneswar would prove crucial," he added. SEE ALSO:<a href="https://www.businessinsider.in/stock-market/webstories/aadhar-housing-finance-ipo-price-band-to-risk-factors-all-you-need-to-know/slidelist/109919298.cms" target="_blank"></a> <a href="https://www.businessinsider.in/stock-market/webstories/aadhar-housing-finance-ipo-price-band-to-risk-factors-all-you-need-to-know/slidelist/109919298.cms" target="_blank">Aadhar Housing Finance IPO – Price band to risk factors, all you need to know</a><a href="https://www.businessinsider.in/business/auto/webstories/top-selling-cars-in-india-in-april-2024-tata-punch-continues-to-dominate/slidelist/109909744.cms" target="_blank"></a> <a href="https://www.businessinsider.in/business/auto/webstories/top-selling-cars-in-india-in-april-2024-tata-punch-continues-to-dominate/slidelist/109909744.cms" target="_blank">Top-selling cars in India in April 2024 – Tata Punch continues to dominate</a><a href="https://www.businessinsider.in/tech/news/worldwide-tablet-shipments-grow-in-q1-2024-after-two-years-of-decline/articleshow/109876390.cms" target="_blank"></a> <a href="https://www.businessinsider.in/tech/news/worldwide-tablet-shipments-grow-in-q1-2024-after-two-years-of-decline/articleshow/109876390.cms" target="_blank">Worldwide tablet shipments grow in Q1 2024 after two years of decline</a>

DRDO to collaborate with IIT Bhubaneswar for AI-driven surveillance, other projects

<ul><li>Glenmark Pharmaceuticals’ subsidiary <keyword id="11114071" type="UNKNOWN" weightage="20" keywordseo="Glenmark-Life-Sciences-IPO">Glenmark Life Sciences IPO</keyword> to open on July 27 and close on July 29.</li><li>It is looking to raise ₹1,060 crore through IPO on a price band of ₹695 to ₹720.</li><li>From the overall IPO proceeds, ₹800 crore will go to the promoter Glenmark Pharmaceuticals as payment for the spin-off.</li></ul>After a strong listing by food delivery firm Zomato last week, Glenmark Pharmaceuticals’ subsidiary <keyword id="11114070" type="COMPANY" weightage="20" keywordseo="glenmark-life-sciences">Glenmark Life Sciences</keyword> is another one in line to launch its initial public offering (IPO). The IPO is likely to open on July 27 and close on July 29. Shares of the company are expected to list on bourses on August 6. Glenmark Life Sciences is a manufacturer of active pharmaceutical ingredients (APIs) catering to chronic therapeutic areas such as cardiovascular disease, central nervous system disorders, pain management, and diabetes, among others. Glenmark Life Sciences has announced to raise ₹1,060 crore through the IPO. From the overall IPO proceeds, ₹800 crore will go to the promoter Glenmark Pharmaceuticals as payment for the spin-off. In 2019, the API manufacturing business of Glenmark was spun off into Glenmark Life Sciences as part of a broader reorganisation focusing on the API business. Further, the company intends to use the proceeds from the IPO for capital expenditure requirements, which includes the expansion of capacity at the Dahej (Gujarat) manufacturing site to meet the anticipated future demand of its generic API products. Here are the important details to note: <table style="border-width: initial; border-style: none;"></colgroup><tbody><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Issue details </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;"> </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Price band </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">₹695-₹720 </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">IPO open date </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">July 27 </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">IPO close date </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">July 29 </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Allotment date </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">August 3 </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Initiation of refunds </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">August 4 </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Credit of shares to demat account </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">August 5 </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">IPO listing date </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">August 6 </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Minimum lot </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">20 </td></tr></tbody></table> Some analysts have recommended subscribing to the IPO because of the company’s good performance over the years, clean regulatory history and the fact that it has a strong promoter holding. “Glenmark Life Sciences has a good performance execution and [a] clean regulatory track record. The company is also a leading developer and manufacturer of select high value, non-commoditised APIs in chronic therapies and works with 16 of the 20 largest generic companies globally. The growth momentum also has a strong undercurrent of global API industry growth. We recommend subscribing to the issue,” said a report by broking firm ICICI Direct. <table style="border-width: initial; border-style: none;"></colgroup><tbody><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Broking house </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Recommendation </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">GEPL Capital Research </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Subscribe </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Choice broking </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Subscribe </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">SMC Finance </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Subscribe for long term </td></tr><tr><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">ICICIdirect </td><td style="border-left:solid #000000 0.8333325pt;border-right:solid #000000 0.8333325pt;border-bottom:solid #000000 0.8333325pt;border-top:solid #000000 0.8333325pt;vertical-align:bottom;padding:2pt 2pt 2pt 2pt;overflow:hidden;overflow-wrap:break-word;">Subscribe </td></tr></tbody></table> Although product concentration remains a key risk where top 10 products contribute 66.36%, the company aims to reduce the dependence with planned capex in FY22, said a report by GEPL Capital Research. “We recommend a subscribe rating to the issue, considering strong research and development (R&amp;D) capabilities, clean regulatory history, strong promoter backing with synergies and planned capex to drive medium term growth,” the report added. Moreover, the company is benefiting from an anti-China product strategy going around the globe. “Except for one antimalarial product segment, our demand outlook, I mean demand that we are getting from customers from the last five quarters has been extremely solid. See, no one is saying that we are buying less from China and more from India, but it is very clear to see that kind of demand. So I believe China Plus One is a real thing,” said Yasir Rajwee, chief executive officer (CEO) of Glenmark Life Sciences in an interview with Business Insider. China Plus One is a business strategy to avoid investing only in China and diversify business into other countries. “Going forward, based on our quick estimate, we are anticipating an 18.7% CAGR [compound annual growth rate] rise in the top-line [revenue] over FY21-24 and margins are also expected to expand… Considering the business growth outlook and almost stable operating margins, we assign a “Subscribe” rating for the issue,” said Choice broking in a report. Further, a report by SMC Finance recommended the IPO for long term on its expansion plans in the next two fiscal years. “Glenmark Life Sciences has generated strong revenue and margin growth in the last 3 years… Moreover, the company intends to increase its API manufacturing capabilities at Ankleshwar facility during FY22, and Dahej facility during FY22 and FY23 by an aggregate annual total installed capacity of 200 kilolitre (KL). This additional production capacity is expected to help the company further expand generic API production and also grow the oncology product pipeline. A long-term investor may opt for the issue,” said the report. SEE ALSO: <a href="https://www.businessinsider.in/stock-market/news/tatva-chintan-pharma-chem-ipo-how-to-check-allotment-status/articleshow/84732059.cms">Tatva Chintan Pharma Chem IPO: How to check allotment status, listing date and more </a> <a href="https://www.businessinsider.in/finance/banks/news/yes-bank-has-reported-its-highest-net-profit-since-december-2018-at-207-crore/articleshow/84678691.cms">YES Bank’s net profit grows four fold as provision for bad loans shrink </a>

One may subscribe to Glenmark Life Sciences IPO because of clean regulatory history, strong promoter backing and good track record, say analysts

<ul><li>The ₹600 crore initial public offering (IPO) of defence components maker <keyword id="370495" type="ORGANIZATION" weightage="20" keywordseo="MTAR-Technologies">MTAR Technologies</keyword> is off to a great start today.</li><li>The company is backed by Mathew Cyriac, the former co-head of private equity firm Blackstone, who is the nominee director of the company.</li><li>It makes a wide range of products that meet the country's nuclear, defence, and space sector's varied requirements.</li><li> ISRO, NPCIL, DRDO, Bloom Energy, Rafael are some of the clients.</li></ul>The ₹600 crore initial public offering (IPO) of defence components maker MTAR Technologies is off to a great start today. In just hours of opening, the issue was subscribed 1.04 times at 11:45 am, and the retail portion received a tremendous response and was subscribed 2.02 times. The Hyderabad-based company kicked off its public offering today, and the issue will remain open for subscription till March 5. The comprises a fresh issue of 21.48 lakh equity shares by the company and an offer for sale (OFS) of 82.24 lakh equity shares by promoters and shareholders. It has fixed the price band at ₹574-575 per share. The company is backed by former Blackstone India honcho Mathew Cyriac. Cyriac is the company's nominee director and has previously been a co-head of private equity firm Blackstone. He also serves as a director on the board of Florintree Advisors, a Mumbai-based alternative asset management firm. <table style="border-width: initial; border-style: none;"></colgroup><tbody><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Brokerage </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Recommendation </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Angel Broking </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Subscribe </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Hem Securities </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Subscribe </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">GEPL Capital </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Subscribe </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">ICICI Direct </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Subscribe </td></tr></tbody></table> Here's what makes the IPO hot! The sector is poised to grow, and its listed peers are proof of that The company, incorporated in 1999, develops and manufactures components and equipment for the defence, aerospace and nuclear energy sectors. It provides a wide range of complex product portfolios that meet the Indian nuclear, defence, and space sector's varied requirements. According to the ICICI Direct report, the industry in which MTAR operates is pegged at ₹4.09 lakh crore and mainly caters to automobile components, industrial plant and equipment segments. The industry contributes an estimated nearly 4% of overall manufacturing output and is expected to grow at a 6-7% compound annual growth rate in fiscal year 2020-25. <div type="image" title="MTAR industry" msid="81306763" hostid="261"></div> The gains in other listed Indian IT stocks are proof of safety that investors have found in the sector. <table style="border-width: initial; border-style: none;"></colgroup><tbody><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Stocks </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Gains since September 30 </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Larsen &amp; Toubro </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">66% </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Shanthi Gears </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">31% </td></tr><tr><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Schaeffler India </td><td style="border-left:solid #000000 0.9907650000000001pt;border-right:solid #000000 0.9907650000000001pt;border-bottom:solid #000000 0.9907650000000001pt;border-top:solid #000000 0.9907650000000001pt;vertical-align:bottom;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">47.25% </td></tr></tbody></table>As of 10:20 am, March 3 The company’s strong customer base and big names on its list make it interesting The company primarily serves customers in the nuclear, space and defence, and clean energy sectors. Indian Space Research Organisation (ISRO), Nuclear Power Corporation of India (NPCIL), Defence Research and Development Organisation (DRDO), Bloom Energy, Rafael Advanced Defense Systems are some of the esteem clients. According to an Axis Capital report, their offerings to ISRO comprised a wide variety of mission-critical components and critical assemblies such as liquid propulsion engines, components and assemblies for cryogenic engines, specifically turbopumps, booster pumps, gas generators and injector heads for such engines, and electro-pneumatic modules to serve its space launch vehicles. As of December 31, the company’s order book was ₹336.19 crore, comprising ₹ 80.19 crore order Book in the clean energy sector, ₹ 93.19 crore in the nuclear sector and ₹ 160.61 crore in space and defence sectors. Strong balance sheet MTAR Tech profit has grown 140% in the last three years from ₹5.4 crore in fiscal year 2018 to ₹31.3 crore in fiscal year 2020. The revenue has also climbed nearly 16% during the same period, which makes it an attractive bet for investors. <div type="image" title="MTAR Tech" msid="81306778" hostid="261"></div> The sector is deemed to grow, and the company offers cut-throat competition to new players. “Owing to the critical end applications of their products and such stringent quality requirements, it becomes very difficult for new players to get qualified for the projects they undertake,” the Axis Capital report highlighted. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/tech/news/indias-new-rules-for-ott-platforms-could-lead-an-increase-in-content-related-disputes/articleshow/81306652.cms">India’s new rules for OTT platforms could lead an increase in content-related disputes</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/finance/news/india-largest-insurer-lic-is-inviting-bids-from-payment-aggregators/articleshow/81304375.cms">EXCLUSIVE: India's largest insurer LIC is inviting bids from payment aggregators⁠</a>

Former Blackstone exec’s firm MTAR Tech’s ₹600 crore IPO⁠ — what works for it and what doesn't

<ul class="summary-list"><li>The construction industry is facing a labor shortage of about 500,000 workers this year.</li><li>The worker shortage is pushing up housing costs amid a national housing shortage. </li></ul>When the pandemic hit the US in the spring of 2020, <a target="_blank" href="https://www.businessinsider.com/housing-market-recovery-mortgage-rates-outlook-inventory-construction-demand-nahb-2024-1">construction</a> projects of all kinds froze and workers were <a target="_blank" href="https://www.cpwr.com/wp-content/uploads/DataBulletin-July2020.pdf">laid off in huge numbers</a>. But as remote work took hold and many sought larger homes, demand for new residential construction quickly picked up and workers were back on the job.That momentum has kept up. Over the last four years, the industry has seen a surge in demand for labor amid <a target="_blank" href="https://www.jchs.harvard.edu/blog/estimating-national-housing-shortfall">a nationwide shortage of housing</a> and a surge in new government funding for <a target="_blank" href="https://www.businessinsider.com/biden-laws-us-infrastructure-invest-funding-2024-3">major infrastructure projects</a>. This year, the construction industry is short about 500,000 workers — and that's "on top of the normal pace of hiring," <a target="_blank" href="https://www.abc.org/News-Media/News-Releases/abc-2024-construction-workforce-shortage-tops-half-a-million">according to</a> a January 2024 news release from the trade group Associated Builders and Contractors. The worker shortage is now the biggest issue builders are facing, experts say."Contractors do tell me that finding workers is their number one problem," Ken Simonson, chief economist at the Associated General Contractors of America, told Business Insider.While the rising cost of housing is in large part a result of <a target="_blank" href="https://www.aeaweb.org/articles?id=10.1257/jep.32.1.3">restrictive zoning laws and building regulations</a>, the construction worker shortage is also pushing up home costs. Fewer construction workers means less — and slower — residential construction, which in turn leads to higher home prices, <a target="_blank" href="https://www.haas.berkeley.edu/wp-content/uploads/Howard_Wang_Zhang_Housing-Supply-and-Construction-Labor-Dayin-Zhang.pdf?ref=thebuildersdaily.com#:~:text=We%20show%20that%20negative%20shocks,2019%2C%20Freddie%20Mac%202017).">according to a 2023 report</a> from researchers at the University of Utah and the University of Wisconsin-Madison."It boils down to that age-old supply and demand in the sense of if there are fewer workers to work on the projects, that's going to elongate the project, the completion, that's going to increase the cost of the project itself," Kit Dickinson, an industry executive at ADP — a human capital management solutions provider — told Business Insider. "Conversely, that creates a great demand for these workers, which can command a higher wage."Builders and infrastructure projects are in desperate need of all kinds of construction workers, but especially skilled tradespeople. Dickinson said there aren't enough plumbers, pipefitters, or people in other trades to meet growing demand.Demand for workers is only expected to rise with the construction of major infrastructure and clean energy projects — in part funded by big federal packages, including the <a target="_blank" href="https://www.businessinsider.com/whats-in-the-infrastructure-bill-amtrak-clean-energy-2021-7">Infrastructure Investment and Jobs Act of 2021</a>, the <a target="_blank" href="https://www.businessinsider.com/house-passes-inflation-reduction-act-sending-it-to-biden-2022-8">Inflation Reduction Act of 2022</a>, and the <a target="_blank" href="https://www.businessinsider.com/chips-act-bill-to-boost-us-chipmaking-competition-with-china-2022-7">CHIPS and Science Act of 2022</a>. Ben Brubeck, vice president of regulatory, labor and state affairs at Associated Builders and Contractors, said the US will see an uptick in demand for skilled tradespeople for these "mega" projects, "not only in their initial construction but also in their operation and maintenance," he added.<h2>Growing the workforce</h2>Both short- and long-term solutions to the worker shortage are key."I think the construction industry has long been saying our workforce is rapidly retiring, and it needs to be replenished," Maja Rosenquist, senior vice president of builder and development company Mortenson, told Business Insider. "We need to be as inclusive as possible to make sure that we've got the right workforce in the future."Simonson said that allowing more <a target="_blank" href="https://www.businessinsider.com/typical-immigrant-united-states-jobs-construction-food-services-florida-california-2024-4">immigrants</a> into the country <a target="_blank" href="https://www.cnn.com/2024/03/21/business/construction-industry-needs-immigrant-workers/index.html">to fill construction jobs</a> is crucial. But the US also needs to create a stronger pipeline of young people interested in pursuing construction as a career, he said. This will require more funding from the federal government, he said, but also more local support."It really also comes down to state and local school district policies and individual guidance counselors, teachers and parents to get the message to kids that there are lucrative, rewarding — both financially and in satisfaction — careers in construction," Simonson said.Brubeck said his organization is trying to promote the trades as a path into the middle class, and potentially to owning a business, as many tradespeople ultimately run their own operations. "We think it's sort of the best-kept secret, the fact that you can earn while you learn. You don't get in this college debt cycle," he said. "And you've got a job ready for you basically right away."The increasing use of technology in construction could also be a draw for younger generations."There's a stronger technology element that people might not be initially aware of and come to understand that construction is a very high-tech industry," Dickinson said, noting the use of technology from the work site to the construction office.That even includes usage of AI, "to help with planning and bidding on future projects, as well as executing projects," Dickinson said.Highlighting the diverse work opportunities in construction could also be helpful for employers and builders looking to increase employment.Rosenquist said it's an "amazing industry in terms of you can pretty much do anything you want to in this industry.""But I think the general population when they think about, oh, my kids going into construction just has this vision of a hard hat and holding a sign," Rosenquist said.President Joe Biden is <a target="_blank" href="https://apnews.com/article/joe-biden-union-endorsement-651dd9dd2eb8e16ab898366e9501dc4e">relying on union support</a> in his re-election campaign and is widely viewed as the <a target="_blank" href="https://www.newyorker.com/news/daily-comment/biden-is-the-most-pro-labor-president-since-fdr-will-it-matter-in-november">most pro-union president</a> since Franklin D. Roosevelt."These are relatively good jobs, especially if they're jobs with unions," Heather Boushey, a member of the president's Council of Economic Advisers and chief economist for Investing in America, told Business Insider in 2023 about construction jobs. "If they're represented by a union, people can know that their safety issues are being focused on by the union and the like."Some experts say the federal government is overly concerned with prioritizing union labor, which makes up a small fraction of the broader construction workforce. By <a target="_blank" href="https://www.whitehouse.gov/omb/briefing-room/2023/12/18/fact-sheet-biden-harris-administration-announces-action-to-support-economic-and-efficient-construction-projects-while-creating-good-paying-and-union-jobs/">requiring union workers</a> for most large federal government-funded projects, "the Biden administration is actually exacerbating the skilled labor shortage that we have because there just isn't enough union labor to do this work," Brubeck said.<h2>Making the industry more appealing to women</h2>Boushey pointed out that the share of women in the overall construction industry has climbed. Experts find attracting more women needs to be a priority in construction.To do so, that would include more accommodations, which Dickinson said "whether it's nursing stations at the job site or daycare, to making the equipment more tailored to different genders and body types as opposed to a one-size-fits-all."Rosenquist said that she's encouraged by the future of prefabricated construction, which could be more attractive to women."Maybe they're going to the same manufacturing facility every single day for five years versus being on a job site where they're changing locations every five months," Rosenquist said.But the construction industry has lost some of its edge as compensation in other industries, including restaurants and hospitality, <a target="_blank" href="https://stateline.org/2024/01/09/hospitality-workers-wages-are-rising-faster-than-high-earners-in-most-states/">has risen</a>, and remote and hybrid jobs offer cushier, more flexible alternatives, Simonson said. The construction industry is also at a disadvantage because most workers can't do manual labor until they retire."I worry that construction is going to keep losing out on workers or have to raise pay even more than the 5% increase that we've seen for the last three years," he said.What is it like working a construction job or dealing with a construction worker shortage in the US? Reach out to these reporters to share at <a target="_blank" href="mailto:mhoff@businessinsider.com">mhoff@businessinsider.com</a> and <a target="_blank" href="mailto:erelman@businessinsider.com">erelman@businessinsider.com</a>.

You Searched For "clean science and technology ipo pricing" and got 12 results

Clean Science and Technology IPO: Shares list at 100% premium on exchanges

Bhakti Makwana

Clean Science and Technology, an Indian supplier to Bayer, has opened its IPO ⁠— and ‘subscribe’ is the unanimous call from analysts

Bhakti Makwana

Clean Science and Technology sets IPO price band at ₹880-900, bidding to start on July 7

Bhakti Makwana

Clean Science and Technology IPO - How to check allotment status, listing date and more

Bhakti Makwana

Clean Science and Technology not to use IPO money to expand as it has enough cash in hand

Bhakti Makwana

Sigachi broke Paras Defence’s record⁠—these are the five IPOs that doubled investors’ money on listing in 2021

Bhakti Makwana

Clean Science and Technology IPO subscribed over 95 times on final day of bidding

Bhakti Makwana

HCL Tech, Adani Group, ITC and other top stocks to watch out for on July 20

Rounak Jain

DRDO to collaborate with IIT Bhubaneswar for AI-driven surveillance, other projects

PTI

One may subscribe to Glenmark Life Sciences IPO because of clean regulatory history, strong promoter backing and good track record, say analysts

Bhakti Makwana

Former Blackstone exec’s firm MTAR Tech’s ₹600 crore IPO⁠ — what works for it and what doesn't

Navdeep Yadav

A national shortage of construction workers is driving high home prices. The industry is struggling to fill the gap.

Eliza Relman,Madison Hoff

Popular Keywords

Buying Guides